A Study to Assess the Analgesic Properties of a Sublingual Wafer Formulation of Ketamine Following Third Molar Extraction

Completed · Phase 2 · Has a placebo group

Conditions studied: Pain

In brief

This is a Phase 2, randomized, multicenter, parallel group, double-blind, dose-ranging, placebo-controlled evaluation of the analgesic efficacy, safety and pharmacokinetics of ketamine sublingual wafer in adult subjects who experience post operative pain after undergoing third molar extraction.

Key facts

Study ID
NCT02199678
Run by
Lotus Clinical Research, LLC
People needed
120
Starts
2014-07-01
Expected to finish
2014-11-01
Last updated by the study team
2014-11-21

Who can join

Age: 18 and older, up to 38. Sex: any. Healthy volunteers: accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.